Comparison of administration of 0.9% Sodium Chloride solution versus Plasma-Lyte 148 versus Compound Sodium LacTate Solution in children admitted to PICU – a randomised controlled trial

niversity of Queensland0 个研究点目标入组 524 人开始时间: 2019年9月9日最近更新: 2021年11月1日

试验速览

暂无简介。

•1. All patients – birth to an age of less than 16 years - admitted to the Paediatric Intensive Care Unit (and)
•2. Attending clinician decides that intravenous fluid therapy is required
•3. Admission Na >130mmol/L
•4. New admissions to ICU within the last 24 hours

•1. Age greater than or equal to 16 years.
•2. Patients admitted with a cardiac condition.
•3. Received intravenous fluid therapy for >4 hours in PICU.
•4. Patients admitted to the ICU with disease-specific protocols that necessitate specific fluid requirements such as: the treatment of burns; following liver transplantation surgery; post renal transplant surgery; diabetic ketoacidosis.
•6. Patients with traumatic brain injury or those considered at risk of developing cerebral edema
•7. Patients with pre-existing kidney disease (chronic kidney disease as defined by KDIGO criteria or under the ongoing care of a nephrologist)
•8. Oncology patients who need hyperhydration.

发起方

niversity of Queensland